·
7 Min Read

Jan. 17, 2020: National Advocacy Update

CDC opioid prescribing guidelines, MIPS eligible clinicians and more in the latest AMA national health care advocacy news.

Advocacy Update
·
4 Min Read

July 13, 2017: National Advocacy Update

AMA urges modifications in opioid prescriber education blueprint; New update provides better Quality Payment Program reporting; Many physicians, still fuzzy on details, feel unprepared for QPP

Advocacy Update
·
3 Min Read

Prior authorization of nonopioid pain care prolongs patient suffering

A 10-day trial yields instant pain relief for a patient, but it takes several months to obtain an insurer’s OK for the treatment.

Prior Authorization
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Dec. 30, 2019

In the news: HPV vaccines, organic pollutants effect on fetal growth, e-cig flavor ban, veterans’ health and pyrethroids association with cardiovascular risks.

Publications & Newsletters
Man using e-cigarette
·
3 Min Read

Vaping: Move to ban some flavors only 1st step in addiction fight

Juul and similar companies can continue to sell menthol-flavored cartridges while open-system flavored e-liquids will remain easy to access. Learn about what should happen next.

Behavioral Health
·
1 Min Read

AMA statement on administration action on e-cigarettes

New policy to address youth e-cigarette epidemic by limiting flavors in some vaping products is a step in the right direction, but does not go far enough

Press Releases
·
3 Min Read

Saving time and lives by increased access to MAT in Pennsylvania

John Gallagher, MD, asked policymakers the hard questions about why barriers to effective treatment were allowed to persist.

Behavioral Health
Graphic of doctors around a petri dish
·
4 Min Read

3 ways to slow spread of deadly antibiotic-resistant infections

Antibiotic-resistant infections kill 35,000-plus Americans annually. Learn what physicians and other health professionals should be doing.

Behavioral Health
Dr. Patrice Harris speaking at an event
·
4 Min Read

Changes overdue on how substance-use disorders are covered, treated

The AMA is “laser-focused” on removing barriers to treatment for opioid-use disorder—including eliminating stigma, says the organization’s president, Patrice A. Harris, MD, MA.

Behavioral Health